MOLECULIN.COM

Moleculin Biotech - Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Eac

Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

http://www.moleculin.com/

OVERVIEW OF moleculin.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR MOLECULIN.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Wednesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 9 reviews

5 star

1

4 star

6

3 star

2

2 star

0

1 star

0

Hey there! Start your review of moleculin.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.9 seconds

FAVICON PREVIEW

16x16
32x32

CONTACTS AT MOLECULIN.COM

WK Consulting

1973 ●●●●●y St.

Ho●●on , TX, 77019

US

713-●●●●5041

wk●●●●@wkconsulting.net

View this contact

WK Consulting

WK Consulting

1973 ●●●●●y St.

Ho●●on , TX, 77019

US

713-●●●●5041

wk●●●●@wkconsulting.net

View this contact

WK Consulting

WK Consulting

1973 ●●●●●y St.

Ho●●on , TX, 77019

US

713-●●●●5041

wk●●●●@wkconsulting.net

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2006 July 05
UPDATED: 2014 May 06
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

19

YEARS
0

MONTHS
13

DAYS

NAME SERVERS

1: ns23.worldnic.com
2: ns24.worldnic.com

REGISTRAR

NETWORK SOLUTIONS, LLC.

WHOIS : whois.networksolutions.com

REFERRED : http://networksolutions.com

CONTENT

PAGES IN
THIS WEBSITE

4

SSL

EXTERNAL LINKS

15

SITE IP

104.196.1.148

LOAD TIME

0.859 sec

SCORE

6.2

PAGE TITLE

Moleculin Biotech - Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Eac | moleculin.com Reviews

<META> DESCRIPTION

Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

<META> KEYWORDS

1 Moleculin

2 STAT3

3 STAT3 inhibitor

4 p-STAT3

5 psoriasis

6 mild-to-moderate psoriasis

7 treatment for psoriasis

8

9 coupons

10 reviews

CONTENT

Page content here

KEYWORDS ON PAGE

children,technology,annamycin,about aml,about ctcl,about brain tumors,cardiotoxicity,multidrug resistance,development pipeline,investors,overview,press releases,company information,stock data,sec filings,corporate governance,about us,scientific advisors

SERVER

nginx

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Moleculin Biotech - Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Eac | moleculin.com Reviews

https://moleculin.com

Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

SUBDOMAINS

ir.moleculin.com

Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Dec 13, 2016. Quarter Ended Sep 30, 2016. Kirin M. Smith. VStock Transfer, LLC.

INTERNAL PAGES

moleculin.com

1

Partnerships & Collaborations - Moleculin Biotech

http://www.moleculin.com/about-moleculin/partnerships

Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Partnerships & Collaborations. Partnerships & Collaborations. DERMIN SP. ZO. O.

2

Moleculin Biotech ‹ Log In

http://www.moleculin.com/wp-admin

Larr; Back to Moleculin Biotech.

3

Overview - Moleculin Biotech

http://www.moleculin.com/product-candidates/overview

Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Annamycin is an anthracyline intended for the treatment of relapsed or refractory acute myel...

4

Board of Directors - Moleculin Biotech

http://www.moleculin.com/about-moleculin/board-of-directors

Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Robert E. George. Michael D. Cannon. Management & Business Advisors. Click Here To Subscribe.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

ir.moleculin.com

News / Events :: Moleculin Biotech, Inc. (MBRX)

http://ir.moleculin.com/news-events

Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. November 30, 2016.

ir.moleculin.com

All SEC Filings :: Moleculin Biotech, Inc. (MBRX)

http://ir.moleculin.com/all-sec-filings

Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Prospectus filed pursuant to Rule 424(b)(4).

ir.moleculin.com

Company Information :: Moleculin Biotech, Inc. (MBRX)

http://ir.moleculin.com/company-information

Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Answers to commonly asked questions. Kirin M. Smith. VStock Transfer, LLC.

ir.moleculin.com

Stock Data :: Moleculin Biotech, Inc. (MBRX)

http://ir.moleculin.com/stock-data

Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Moleculin Biotech, Inc.

vanlatham.com

Van M. Latham, Ph.D. - Board of Directors, Strategic Advising, and Angel Investments

http://www.vanlatham.com/boards_investments.html

Dr Van M. Latham Info. Where to Find Me. 1421 Orleans Road * Suite 301 * East Harwich, MA 02645. 3839 McKinney Avenue * Suite 155-731 * Dallas, TX 75204. Ph: 508.631.3174 Fax: 508.432.0826.

pathpointconsulting.com

Van M. Latham, Ph.D. - Board of Directors, Strategic Advising, and Angel Investments

http://www.pathpointconsulting.com/boards_investments.html

Dr Van M. Latham Info. Where to Find Me. 1421 Orleans Road * Suite 301 * East Harwich, MA 02645. 3839 McKinney Avenue * Suite 155-731 * Dallas, TX 75204. Ph: 508.631.3174 Fax: 508.432.0826.

ir.moleculin.com

Moleculin Presents Preclinical Data of Novel Inhibitor of Glycolysis at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics :: Moleculin Biotech, Inc. (MBRX)

http://ir.moleculin.com/press-releases/detail/26/moleculin-presents-preclinical-data-of-novel-inhibitor-of

Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Moleculin Presents Preclinical Data of Novel Inhibitor&#8230. December 13, 2016. Moleculin's Ch...

ir.moleculin.com

Press Releases :: Moleculin Biotech, Inc. (MBRX)

http://ir.moleculin.com/press-releases

Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Moleculin to Present at the 29th Annual Roth Capital Conference. Mar 10, 2017. Feb 9, 2017.

ir.moleculin.com

Financial Information :: Moleculin Biotech, Inc. (MBRX)

http://ir.moleculin.com/financial-information

Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Quarter Ended Sep 30, 2016. View the latest financials.

UPGRADE TO PREMIUM TO VIEW 6 MORE

TOTAL LINKS TO THIS WEBSITE

15

SOCIAL ENGAGEMENT

sharer/sharer.php

moleculinbio

OTHER SITES

moleculez.net

UNDER CONSTRUCTION

Is currently UNDER CONSTRUCTION. This Web site is currently under construction. Please be sure to visit this Web site again in the near future! This is your current default homepage; it has been setup with your new account. To update this Under Construction page, please replace your index.html file.

moleculia-walks-the-walk.blogspot.com

Moleculia Walks the Walk

Moleculia Walks the Walk. Monday, January 10, 2011. 3 new Australian Terrier videos are added today. Click here to go to the page. Links to this post. Tuesday, December 28, 2010. Talking about REACH AND DRIVE! Click the picture to go to the movie! Links to this post. Oelmuhle, adult female on the move. An other nice movie of an adult female on the move at Oelmuhle. Click here to see the movie. Links to this post. Sunday, December 26, 2010. Links to this post. Links to this post. New Section, Fun videos.

moleculia.com

Home

Moleculia Walks the Walk. 2010 henny Contact Me. Moleculia Walks the Walk. Movement - the act of moving. Movement is a measure of a dog's conformation. But how is a specific breed supposed to move? The standard tells us what the movement should be, but many times the standard is misinterpreted. The only way to determen correct movement is to evaluate movement. How? By looking at it.

moleculia.nl

Home

Moleculia Walks the Walk. 2010 henny Contact Me. Moleculia Walks the Walk. Movement - the act of moving. Movement is a measure of a dog's conformation. But how is a specific breed supposed to move? The standard tells us what the movement should be, but many times the standard is misinterpreted. The only way to determen correct movement is to evaluate movement. How? By looking at it.

moleculight.com

MolecuLight | Imaging Device To Visualize Bacteria In Wounds

8211; Main Menu –. The invisible is now visible. Empowering clinicians with information. Impacting patient lives at the point-of-care. MolecuLight is developing a handheld optical imaging technology to visualize bacteria in real-time at the point of care. The device will provide real-time bacteriological information which is otherwise unobtainable using industry standard wound assessment techniques, including conventional white light visualization. See the latest scientific updates.

moleculin.com

Moleculin Biotech - Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Eac

Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Annamycin vs. Daunorubicin. Management & Business Advisors. Partnerships & Collaborations. Better Target, Better Outcomes:. Advancing breakthrough therapeutic approaches to cancer.

moleculinair.net

Moleculinair.net | Uw online winkel voor moleculair koken

Ldquo; Uw online winkel voor moleculair koken ”. Met trots heten we u welkom op de website van moleculinair.net. Gepubliceerd op dinsdag 11 augustus 2015. Dit is een test nieuws bericht met een plaatje. Lees verder ». Office 309 / Tijs.

moleculinary.com

The domain name is registered

THE DOMAIN NAME IS REGISTERED. DOMÉNA JE ZAREGISTROVÁNA. A DOMAIN NÉV REGISZTRÁLT.

moleculious.com

My Site

This is my site description. A website created by GoDaddy’s Website Builder.

moleculis.org

www.moleculis.org

moleculita.blogspot.com

Moleculita

No hay ninguna entrada. No hay ninguna entrada. Suscribirse a: Entradas (Atom).